These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 444789)

  • 21. Tricyclic antidepressants in the treatment of depressions. A double-blind clinical comparison of clomipramine (Anafranil) and amitriptyline.
    Kampman R; Nummikko-Pelkonen A; Kuha S
    Acta Psychiatr Scand; 1978 Aug; 58(2):142-8. PubMed ID: 358754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of clomipramine and desmethylclomipramine in plasma by means of liquid chromatography.
    Westenberg HG; Drenth BF; de Zeeuw RA; de Cuyper H; van Praag HM; Korf J
    J Chromatogr; 1977 Nov; 142():725-33. PubMed ID: 914945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind trial with oral versus intravenous clomipramine in primary depression.
    Faravelli C; Broadhurst AD; Ambonetti A; Ballerini A; De Biase L; La Malfa G; Das M
    Biol Psychiatry; 1983 Jun; 18(6):695-706. PubMed ID: 6871303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorimipramine in obsessional states. (A pilot study).
    Capstick N
    Psychosomatics; 1971; 12(5):332-5. PubMed ID: 5172935
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of clomipramine in dogs following single-dose and repeated-dose oral administration.
    King JN; Maurer MP; Altmann BO; Strehlau GA
    Am J Vet Res; 2000 Jan; 61(1):80-5. PubMed ID: 10630784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of clomipramine during pregnancy.
    Ter Horst PG; Proost JH; Smit JP; Vries MT; de Jong-van de Berg LT; Wilffert B
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1493-500. PubMed ID: 26416100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary observations of the significance of monitoring tricyclic antidepressant plasma levels in the pediatric patient.
    Dugas M; Zarifian E; Leheuzey MF; Rovei V; Durand G; Morselli PL
    Ther Drug Monit; 1980; 2(4):307-14. PubMed ID: 7222184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
    Mavissakalian M; Jones B; Olson S; Perel JM
    Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in plasma concentrations of clomipramine and desmethylclomipramine during clomipramine therapy.
    Hullin RP
    Postgrad Med J; 1980; 56 Suppl 1():117-9. PubMed ID: 7190279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of clomipramine on depression in Barbadian patients.
    Mahy GE
    West Indian Med J; 1978 Jun; 27(2):75-80. PubMed ID: 695554
    [No Abstract]   [Full Text] [Related]  

  • 31. [Psychopharmacological treatment of obsessive neurosis].
    Lopez-Ibor Aliño JJ; Lopez-Ibor Aliño JM
    Arzneimittelforschung; 1974 Aug; 24(8):1119-22. PubMed ID: 4153642
    [No Abstract]   [Full Text] [Related]  

  • 32. Single versus divided daily dosages of clomipramine. Plasma concentration and clinical effect.
    Dencker SJ; Nagy A
    Acta Psychiatr Scand; 1979 Mar; 59(3):326-34. PubMed ID: 373391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between clinical response, plasma levels and side-effects of clomipramine (Anafranil) in general practitioner trials.
    Miller P; Luscombe DK; Jones RB; Seldrup J; Beaumont G; John V
    J Int Med Res; 1977; 5(1 Suppl):108-18. PubMed ID: 863079
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.
    Vandel B; Vandel S; Jounet JM; Allers G; Volmat R
    Eur J Clin Pharmacol; 1982; 22(1):15-20. PubMed ID: 7094971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mianserin and clomipramine in the treatment of depression.
    Levin A
    S Afr Med J; 1982 May; 61(19):701-4. PubMed ID: 7043754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--I. Report on an uncontrolled clinical trial.
    Campbell P; Ananth JV; Gomez L
    Psychopharmacol Bull; 1976 Jan; 12(1):23-4. PubMed ID: 1108077
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--IV. A summary report.
    Lehmann HE; Ban TA; Pecknold JC
    Psychopharmacol Bull; 1976 Jan; 12(1):27-9. PubMed ID: 1108080
    [No Abstract]   [Full Text] [Related]  

  • 38. Potentiation of the antidepressant action of clomipramine by tryptophan.
    Walinder J; Skott A; Carlsson A; Nagy A; Bjorn-Erik R
    Arch Gen Psychiatry; 1976 Nov; 33(11):1384-9. PubMed ID: 985049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study of anafranil in the treatment of phobic states.
    Colgan A
    Scott Med J; 1975; 20(1 SUPPL):55-60. PubMed ID: 1154016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.